Half of over 75s in US are taking cholesterol lowering drugs, report says
Lenzer, J.
Bmj 349: G7820
2014
ISSN/ISBN: 0959-8138 PMID: 25547824 Document Number: 677981
Document emailed within 1 workday
Related Documents
Henry, D.A.; Cully, L.R.; Grigson, T.; Lee, C. 1991: Recent trends in the prescribing of cholesterol lowering drugs in Australia. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee Medical Journal of Australia 155(5): 332-336Amarasingham, R. 1990: Cholesterol lowering drugs New Zealand Medical Journal 103(886): 138
Faergeman, O. 1994: Cholesterol lowering drugs Ugeskrift for Laeger 156(3): 328-329
Fretheim, A.; Bjørndal, A.; Oxman, A.D.; Dyrdal, A.; Golding, M.; Ose, L.; Reikvam, A.; Teisberg, P. 2002: Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(23): 2287-2288
2005: Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source MMW Fortschritte der Medizin 147(23): 48-49
Hoppichler, F.; Lechleitner, M.; Patsch, J.R. 1992: Pravastatin, a new cholesterol synthesis inhibitor for lowering increased serum cholesterol Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(11): 523-527
Stoy, N. 1997: Influence of cholesterol on survival after stroke. Beneficial effects of cholesterol lowering on atherosclerosis may not lessen with age Bmj 315(7116): 1158; Author Reply 1159
Moyad, M.A.; Merrick, G.S. 2006: Cholesterol, cholesterol lowering agents/statins, and urologic disease: part i - knowing your numbers Urologic Nursing 26(2): 156-159
Grundy, S.M.; Cleeman, J.I.; Rifkind, B.M.; Kuller, L.H. 1999: Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program Archives of Internal Medicine 159(15): 1670-1678
Westendorp, R.G.; Smelt, A.H. 1996: Cholesterol synthesis inhibitors: lowering of cholesterol for everybody? Nederlands Tijdschrift Voor Geneeskunde 140(8): 411-414
Simoons, M.L.; Casparie, A.F. 1998: Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO Nederlands Tijdschrift Voor Geneeskunde 142(38): 2096-2101
Griffin, K.W.; Weidner, G. 1994: Cholesterol-lowering and psychological well-being Comprehensive Therapy 20(9): 518-522
Auer, J.; Berent, R.; Weber, T.; Porodko, M.; Mayr, H.; Maurer, E.; Eber, B. 2001: Pharmacologic interventions in primary prevention: lipid lowering drugs, aspirin, antiobesity drugs, and antihypertensive agents Wiener Medizinische Wochenschrift 151(1-2): 13-17
Smith, S.C. 1998: Lessons from cholesterol-lowering trials American Journal of Medicine 104(6a): 28s-32s
Guo, Y.-f.; Hu, D.-y. 2007: Statins in lowering cholesterol in the elderly Zhonghua Nei Ke Za Zhi 46(11): 893-894
Thompson, G.R. 1999: Cholesterol lowering margarine is effective Bmj 319(7218): 1200-1201
1986: Lowering plasma cholesterol by diet New England Journal of Medicine 315(9): 585-587
1986: Lowering of cholesterol levels in fat imbalance disorders Medizinische Monatsschrift für Pharmazeuten 9(9): 274-276
1999: Cholesterol-lowering margarine expected out this year Mayo Clinic Health Letter 17(2): 4
Beranek, J.T. 1993: Cholesterol lowering trials and the theory of atherosclerosis New Zealand Medical Journal 106(953): 143-144